Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
$23.95
+1.2%
$24.17
$18.19
$25.53
$11.28B0.67363,476 shs117,439 shs
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
$252.23
+1.1%
$233.59
$187.30
$252.92
$26.38B0.46874,734 shs388,133 shs
First Horizon Corporation stock logo
FHN
First Horizon
$21.51
+1.6%
$21.11
$14.82
$23.00
$10.91B0.656.36 million shs4.61 million shs
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
$35.27
+8.4%
$0.00
$18.13
$49.34
$2.73BN/A644,091 shs415,945 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
+1.98%+2.93%-4.43%-3.97%+23.90%
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
+0.56%+3.51%+7.29%+7.68%+24,949,999,900.00%
First Horizon Corporation stock logo
FHN
First Horizon
-1.17%-3.08%-3.77%+9.78%+44.55%
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
+2.19%-7.80%-7.97%-25.42%+79.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
2.5414 of 5 stars
0.83.03.30.01.90.03.8
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
2.5709 of 5 stars
2.00.01.72.53.22.51.3
First Horizon Corporation stock logo
FHN
First Horizon
4.8691 of 5 stars
2.45.02.53.33.52.53.1
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
1.3257 of 5 stars
3.40.01.70.00.60.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
1.67
Reduce$23.00-3.98% Downside
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
1.93
Reduce$231.38-8.26% Downside
First Horizon Corporation stock logo
FHN
First Horizon
2.71
Moderate Buy$23.288.26% Upside
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
2.75
Moderate Buy$45.4328.82% Upside

Current Analyst Ratings Breakdown

Latest MRX, CBOE, BSAC, and FHN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/4/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$254.00
8/4/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$243.00 ➝ $248.00
8/4/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$250.00 ➝ $265.00
8/4/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$243.00 ➝ $256.00
8/4/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$245.00 ➝ $255.00
8/4/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$253.00 ➝ $265.00
7/17/2025
First Horizon Corporation stock logo
FHN
First Horizon
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$22.00 ➝ $25.00
7/17/2025
First Horizon Corporation stock logo
FHN
First Horizon
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$26.00 ➝ $27.00
7/15/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$249.00 ➝ $253.00
7/15/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$245.00 ➝ $250.00
7/15/2025
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetUnderweight ➝ Underweight$215.00 ➝ $218.00
(Data available from 8/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
$4.72B2.39$2.28 per share10.52$12.51 per share1.91
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
$4.09B6.44$12.99 per share19.42$40.88 per share6.17
First Horizon Corporation stock logo
FHN
First Horizon
$3.09B3.53$1.86 per share11.57$17.41 per share1.24
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
$1.24B1.99N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
$938.26M$2.409.9810.510.8824.32%22.21%1.57%N/A
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
$764.90M$8.5334.9326.081.7518.64%22.02%10.73%N/A
First Horizon Corporation stock logo
FHN
First Horizon
$775M$1.5513.8711.261.0117.10%10.55%1.13%10/15/2025 (Estimated)
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
$141.30MN/A0.0012.04N/AN/AN/AN/AN/A

Latest MRX, CBOE, BSAC, and FHN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/1/2025N/A
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
$2.43$2.46+$0.03N/AN/AN/A
7/31/2025Q2 2025
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
$0.62$0.60-$0.02$0.60$758.17 million$757.38 million
7/16/2025Q2 2025
First Horizon Corporation stock logo
FHN
First Horizon
$0.41$0.45+$0.04$0.45$832.95 million$830.19 million
5/18/2025N/A
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
$0.90$0.97+$0.07N/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
$0.994.13%N/A41.25%N/A
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
$2.521.00%N/A29.54%1 Years
First Horizon Corporation stock logo
FHN
First Horizon
$0.602.79%N/A38.71%N/A
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
$0.561.59%N/AN/AN/A

Latest MRX, CBOE, BSAC, and FHN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2025
First Horizon Corporation stock logo
FHN
First Horizon
quarterly$0.152.69%9/12/20259/12/202510/1/2025
5/13/2025
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
quarterly$0.151.23%5/27/20255/27/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
2.61
1.76
1.76
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
0.34
1.78
1.39
First Horizon Corporation stock logo
FHN
First Horizon
0.15
0.96
0.95
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
1.18
1.04
1.08

Institutional Ownership

CompanyInstitutional Ownership
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
6.42%
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
82.67%
First Horizon Corporation stock logo
FHN
First Horizon
80.28%
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Banco Santander Chile stock logo
BSAC
Banco Santander Chile
8,757471.11 millionN/AOptionable
Cboe Global Markets, Inc. stock logo
CBOE
Cboe Global Markets
1,540104.59 million104.46 millionN/A
First Horizon Corporation stock logo
FHN
First Horizon
7,252507.23 million502.82 millionOptionable
Medicis Pharmaceutical Corp stock logo
MRX
Medicis Pharmaceutical
2,07470.29 million67.63 millionOptionable

Recent News About These Companies

Marex Group plc issues statement regarding NINGI Research report
Close Brothers agrees £104 million sale of Winterflood to Marex
Best Value Stocks to Buy for July 17th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Banco Santander Chile stock logo

Banco Santander Chile NYSE:BSAC

$23.95 +0.27 (+1.15%)
As of 03:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Banco Santander-Chile, together with its subsidiaries, provides commercial and retail banking services in Chile. It operates through Retail Banking, Middle-Market, Corporate Investment Banking, and Corporate Activities segments. The company offers debit and credit cards, checking accounts, and savings products; consumer, automobile, commercial, mortgage, and government-guaranteed loans; and Chilean peso and foreign currency-denominated loans to finance various commercial transactions, trade, foreign currency forward contracts, and credit lines, as well as mortgage financing services. It also provides mutual fund management, insurance and securities brokerage, foreign exchange services, financial leasing, financial consulting and advisory, investment management, foreign trade, leasing, factoring, treasury, and transactional services, as well as specialized services to finance residential projects. In addition, the company offers short-term financing and fundraising, and brokerage services, as well as derivatives, securitization, and other products; and manages capital allocations. It serves individuals, small to middle-sized entities, companies, and large corporations, as well as universities, government entities, and local and regional governments. The company was incorporated in 1977 and is headquartered in Santiago, Chile. Banco Santander-Chile operates as a subsidiary of Banco Santander, S.A.

Cboe Global Markets stock logo

Cboe Global Markets NASDAQ:CBOE

$252.23 +2.73 (+1.09%)
As of 03:16 PM Eastern

Cboe Global Markets, Inc. is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. Cboe offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded products (ETPs), global foreign exchange (FX) and multi-asset volatility products based on the VIX Index. Cboe's trading venues include the largest options exchange in the United States and the largest stock exchange by value traded in Europe. CBOE reports the results of its operations in 5 business segments: Options, Futures, U.S. Equities, European Equities, and Global FX.

First Horizon stock logo

First Horizon NYSE:FHN

$21.50 +0.35 (+1.63%)
As of 03:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

First Horizon Corporation operates as the bank holding company for First Horizon Bank that provides various financial services. The company operates through Regional Banking and Specialty Banking segments. It offers general banking services for consumers, businesses, financial institutions, and governments. The company also accepts deposits; provides underwriting services for bank-eligible securities and other fixed-income securities by financial subsidiaries; sells loans and derivatives; financial planning; and offers investment and financial advisory services. In addition, it offers mortgage banking; loan syndications; brokerage services; commercial and business banking for business enterprises, consumer banking, and private client and wealth management services; capital markets, professional commercial real estate, mortgage warehouse and asset-based lending, franchise and equipment finance, tax credit finance, energy and healthcare finance, asset management, and corporate and correspondent banking services. Further, the company provides transaction processing services including check clearing services and remittance processing, credit cards, investment, and sale of mutual fund and retail insurances, as well as trust, fiduciary, and agency services. First Horizon Corporation was founded in 1864 and is headquartered in Memphis, Tennessee.

Medicis Pharmaceutical stock logo

Medicis Pharmaceutical NYSE:MRX

Medicis Pharmaceutical Corporation (Medicis) together with its wholly owned subsidiaries is an independent specialty pharmaceutical company engaged in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States and Canada. Medicis offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles. Its brands are DYSPORT (abobotulinumtoxinA) 300 Units for Injection, PERLANE Injectable Gel, RESTYLANE Injectable Gel, SOLODYN (minocycline HCl, USP) Extended Release Tablets, VANOS (fluocinonide) Cream 0.1%, ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel and ZYCLARA (imiquimod) Cream 3.75% and 2.5%. As of December 31, 2011, it offered 27 branded products. On December 2, 2011, it acquired Graceway Pharmaceuticals, LLC (Graceway). On November 1, 2011, Medicis sold Medicis Technologies Corporation, formerly LipoSonix, Inc., to Solta Medical, Inc. (Solta).